Global Opioid Use Disorder (OUD) Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032

Industry: Healthcare
RELEASE DATE Mar 2025
REPORT ID SI2364
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Route of Administration
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising prevalence of opioid addiction
    3. Restraints
      1.  Strict regulatory policies
    4. Opportunities
      1.  Non-opioid-based therapies and digital health solutions to improve access to treatment and reduce dependency risks
    5. Challenges
      1. Limited access to effective treatments due to regulatory barriers
  6. Global Opioid Use Disorder (OUD) Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Buprenorphine
    3. Methadone
    4. Naltrexone
  7. Global Opioid Use Disorder (OUD) Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Parenteral
  8. Global Opioid Use Disorder (OUD) Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies & Stores
    4. Online Pharmacies
  9. Global Opioid Use Disorder (OUD) Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Opioid Use Disorder (OUD) Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Opioid Use Disorder (OUD) Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Indivior PLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Alkermes 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Orexo AB 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Titan Pharmaceuticals, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Mallinckrodt Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  BioDelivery Sciences International Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Viatris Inc. (Mylan N.V.)
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Hikma Pharmaceuticals PLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Camurus
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  2. Global Buprenorphine, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  3. Global Methadone, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  4. Global Naltrexone, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  5. Global Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  6. Global Oral, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  7. Global Parenteral, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  8. Global Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  9. Global Hospital Pharmacies, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  10. Global Retail Pharmacies & Stores, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  11. Global Online Pharmacies, Opioid Use Disorder (OUD) Market, By Region, 2023-2033(USD Billion)
  12. North America Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  13. North America Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  14. North America Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  15. U.S.  Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  16. U.S.  Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  17. U.S.  Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  18. Canada Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  19. Canada Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  20. Canada Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  21. Mexico Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  22. Mexico Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  23. Mexico Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  24. Europe Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  25. Europe Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  26. Europe Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  27. Germany Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  28. Germany Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  29. Germany Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  30. France Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  31. France Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  32. France Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  33. U.K.  Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  34. U.K.  Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  35. U.K.  Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  36. Italy Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  37. Italy Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  38. Italy Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  39. Spain Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  40. Spain Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  41. Spain Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  42. Asia Pacific Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  43. Asia Pacific Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  44. Asia Pacific Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  45. Japan Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  46. Japan Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  47. Japan Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  48. China Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  49. China Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  50. China Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  51. India Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  52. India Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  53. India Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  54. South America Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  55. South America Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  56. South America Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  57. Brazil Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  58. Brazil Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  59. Brazil Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  60. The Middle East and Africa Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD   Billion)
  61. The Middle East and Africa Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD   Billion)
  62. The Middle East and Africa Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  63. UAE Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  64. UAE Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  65. UAE Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)
  66. South Africa Opioid Use Disorder (OUD) Market, By Drug Class, 2023-2033(USD Billion)
  67. South Africa Opioid Use Disorder (OUD) Market, By Route of Administration, 2023-2033(USD Billion)
  68. South Africa Opioid Use Disorder (OUD) Market, By Distribution Channel, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Opioid Use Disorder (OUD) Market Segmentation
  2. Opioid Use Disorder (OUD) Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Opioid Use Disorder (OUD) Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Opioid Use Disorder (OUD) Market
  20. Opioid Use Disorder (OUD) Market Segmentation, By Drug Class
  21. Opioid Use Disorder (OUD) Market For Buprenorphine, By Region, 2023-2033 ($ Billion)
  22.  Opioid Use Disorder (OUD) Market For Methadone, By Region, 2023-2033 ($ Billion)
  23. Opioid Use Disorder (OUD) Market For Naltrexone, By Region, 2023-2033 ($ Billion)
  24.  Opioid Use Disorder (OUD) Market Segmentation, By Route of Administration
  25.  Opioid Use Disorder (OUD) Market For Oral, By Region, 2023-2033 ($ Billion)
  26.  Opioid Use Disorder (OUD) Market For Parenteral, By Region, 2023-2033 ($ Billion)
  27. Opioid Use Disorder (OUD) Market Segmentation, By Distribution Channel
  28. Opioid Use Disorder (OUD) Market For Hospital Pharmacies, By Region, 2023-2033 ($ Billion)
  29. Opioid Use Disorder (OUD) Market For Retail Pharmacies & Stores, By Region, 2023-2033 ($ Billion)
  30. Opioid Use Disorder (OUD) Market For Online Pharmacies, By Region, 2023-2033 ($ Billion)
  31. Indivior PLC: Net Sales, 2023-2033 ($ Billion)
  32. Indivior PLC: Revenue Share, By Segment, 2023 (%)
  33. Indivior PLC: Revenue Share, By Region, 2023 (%)
  34. Alkermes: Net Sales, 2023-2033 ($ Billion)
  35. Alkermes: Revenue Share, By Segment, 2023 (%)
  36. Alkermes: Revenue Share, By Region, 2023 (%)
  37. Orexo AB: Net Sales, 2023-2033 ($ Billion)
  38. Orexo AB: Revenue Share, By Segment, 2023 (%)
  39. Orexo AB: Revenue Share, By Region, 2023 (%)
  40. Titan Pharmaceuticals, Inc.: Net Sales, 2023-2033 ($ Billion)
  41. Titan Pharmaceuticals, Inc.: Revenue Share, By Segment, 2023 (%)
  42. Titan Pharmaceuticals, Inc.: Revenue Share, By Region, 2023 (%)
  43. Mallinckrodt Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  44. Mallinckrodt Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  45. Mallinckrodt Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  46. BioDelivery Sciences International Inc.: Net Sales, 2023-2033 ($ Billion)
  47. BioDelivery Sciences International Inc.: Revenue Share, By Segment, 2023 (%)
  48. BioDelivery Sciences International Inc.: Revenue Share, By Region, 2023 (%)
  49. Viatris Inc. (Mylan N.V.): Net Sales, 2023-2033 ($ Billion)
  50. Viatris Inc. (Mylan N.V.): Revenue Share, By Segment, 2023 (%)
  51. Viatris Inc. (Mylan N.V.): Revenue Share, By Region, 2023 (%)
  52. Hikma Pharmaceuticals PLC: Net Sales, 2023-2033 ($ Billion)
  53. Hikma Pharmaceuticals PLC: Revenue Share, By Segment, 2023 (%)
  54. Hikma Pharmaceuticals PLC: Revenue Share, By Region, 2023 (%)
  55. Camurus.: Net Sales, 2023-2033 ($ Billion)
  56. Camurus.: Revenue Share, By Segment, 2023 (%)
  57. Camurus.: Revenue Share, By Region, 2023 (%)
  58. Others: Net Sales, 2023-2033 ($ Billion)
  59. Others: Revenue Share, By Segment, 2023 (%)
  60. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:10.7%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies